New arrangements for migalastat (Galafold®) – information for prescribers
About this resource
Publication date:
Publication type:
Fact sheet
Language:
English
Australian Government Department of Health, Disability and Ageing
New arrangements for migalastat (Galafold®) – information for prescribers
This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.